Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bowel preparation strategies based on bowel habits (BSFS 1–2)
ChiCTR2100050437Phase 4Not yet recruiting
- Sponsor
- Tongji Hospital
- Start
- Aug 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of linaclotide in constipation and inadequate bowel preparation (IBP) (3 arms), sponsored by Tongji Hospital. Primary endpoint: Degree of bowel cleansing. Planned start Aug 2021; status: not yet recruiting.
02
Drugs
linaclotide
03
Conditions
constipationinadequate bowel preparation (IBP)
Beyond the preview
Go deeper on ChiCTR2100050437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050437.